News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,359 Results
Type
Article (43012)
Company Profile (106)
Press Release (575230)
Multimedia
Podcasts (94)
Webinars (19)
Section
Business (163005)
Career Advice (2465)
Deals (29812)
Drug Delivery (117)
Drug Development (74103)
Employer Resources (146)
FDA (14680)
Job Trends (13345)
News (287602)
Policy (28601)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2646)
Academic (1)
Accelerated approval (33)
Adcomms (31)
Allergies (144)
Alliances (41792)
ALS (175)
Alzheimer's disease (1700)
Antibody-drug conjugate (ADC) (320)
Approvals (14914)
Artificial intelligence (532)
Autoimmune disease (150)
Automation (39)
Bankruptcy (320)
Best Places to Work (10888)
BIOSECURE Act (18)
Biosimilars (197)
Biotechnology (69)
Bladder cancer (156)
Brain cancer (58)
Breast cancer (627)
Cancer (4745)
Cardiovascular disease (415)
Career advice (2092)
Career pathing (36)
CAR-T (264)
CDC (49)
Cell therapy (706)
Cervical cancer (32)
Clinical research (63682)
Collaboration (1581)
Company closure (4)
Compensation (632)
Complete response letters (64)
COVID-19 (2666)
CRISPR (90)
C-suite (910)
Cystic fibrosis (127)
Data (6125)
Decentralized trials (2)
Denatured (21)
Depression (146)
Diabetes (498)
Diagnostics (6561)
Digital health (44)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (240)
Drug pricing (191)
Drug shortages (26)
Duchenne muscular dystrophy (239)
Earnings (61596)
Editorial (62)
Employer branding (19)
Employer resources (137)
Events (102807)
Executive appointments (1017)
FDA (17714)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1377)
Gene editing (190)
Generative AI (51)
Gene therapy (605)
GLP-1 (977)
Government (4592)
Grass and pollen (7)
Guidances (380)
Healthcare (18177)
HIV (62)
Huntington's disease (46)
IgA nephropathy (86)
Immunology and inflammation (273)
Immuno-oncology (61)
Indications (115)
Infectious disease (2949)
Inflammatory bowel disease (188)
Inflation Reduction Act (15)
Influenza (118)
Intellectual property (238)
Interviews (527)
IPO (13401)
IRA (53)
Job creations (2810)
Job search strategy (1688)
JPM (64)
Kidney cancer (18)
Labor market (62)
Layoffs (519)
Leadership (39)
Legal (6202)
Liver cancer (91)
Longevity (14)
Lung cancer (673)
Lymphoma (370)
Machine learning (34)
Management (53)
Manufacturing (711)
MASH (179)
Medical device (12411)
Medtech (12463)
Mergers & acquisitions (17428)
Metabolic disorders (1285)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (328)
Neuropsychiatric disorders (99)
Neuroscience (2957)
Neurotech (1)
NextGen: Class of 2026 (6194)
Non-profit (4275)
Now hiring (56)
Obesity (593)
Opinion (285)
Ovarian cancer (163)
Pain (203)
Pancreatic cancer (225)
Parkinson's disease (275)
Partnered (28)
Patents (480)
Patient recruitment (488)
Peanut (55)
People (55136)
Pharmaceutical (27)
Pharmacy benefit managers (25)
Phase 1 (19568)
Phase 2 (27953)
Phase 3 (21416)
Pipeline (5351)
Policy (294)
Postmarket research (2362)
Preclinical (7961)
Press Release (55)
Prostate cancer (237)
Psychedelics (56)
Radiopharmaceuticals (270)
Rare diseases (862)
Real estate (4559)
Recruiting (62)
Regulatory (22187)
Reports (31)
Research institute (2289)
Resumes & cover letters (359)
Rett syndrome (26)
RNA editing (17)
RSV (76)
Schizophrenia (155)
Series A (226)
Series B (180)
Service/supplier (4)
Sickle cell disease (101)
Special edition (20)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3048)
State (2)
Stomach cancer (19)
Supply chain (95)
Tariffs (77)
The Weekly (72)
Vaccines (981)
Venture capital (89)
Weight loss (391)
Women's health (85)
Worklife (20)
Date
Today (115)
Last 7 days (623)
Last 30 days (2155)
Last 365 days (28284)
2026 (3893)
2025 (28615)
2024 (32894)
2023 (36920)
2022 (47647)
2021 (51728)
2020 (50403)
2019 (43652)
2018 (32930)
2017 (28793)
2016 (28040)
2015 (32944)
2014 (25117)
2013 (20522)
2012 (21816)
2011 (22737)
2010 (20106)
Location
Africa (787)
Alabama (82)
Alaska (4)
Arizona (244)
Arkansas (12)
Asia (36965)
Australia (7377)
California (10266)
Canada (3148)
China (1060)
Colorado (447)
Connecticut (418)
Delaware (326)
Europe (83886)
Florida (1609)
Georgia (347)
Hawaii (2)
Idaho (56)
Illinois (843)
India (67)
Indiana (499)
Iowa (17)
Japan (423)
Kansas (112)
Kentucky (37)
Louisiana (27)
Maine (67)
Maryland (1307)
Massachusetts (7273)
Michigan (328)
Minnesota (562)
Mississippi (5)
Missouri (135)
Montana (26)
Nebraska (25)
Nevada (115)
New Hampshire (78)
New Jersey (2918)
New Mexico (23)
New York (2750)
North Carolina (1328)
North Dakota (7)
Northern California (5004)
Ohio (313)
Oklahoma (14)
Oregon (32)
Pennsylvania (2151)
Puerto Rico (24)
Rhode Island (41)
South America (1052)
South Carolina (65)
South Dakota (1)
Southern California (4066)
Tennessee (160)
Texas (1642)
United States (37015)
Utah (333)
Vermont (1)
Virginia (254)
Washington D.C. (77)
Washington State (851)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
618,359 Results for "celltrion healthcare formerly known as celltrion.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Press Releases
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
January 14, 2026
·
6 min read
Press Releases
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
January 16, 2026
·
5 min read
Press Releases
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector
December 18, 2025
·
6 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
January 6, 2026
·
8 min read
Press Releases
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg
November 18, 2025
·
4 min read
Press Releases
Celltrion receives Health Canada approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg)
November 28, 2025
·
3 min read
Press Releases
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
October 3, 2025
·
9 min read
Press Releases
Kaigene Enters into Exclusive Licensing Agreement with Celltrion for Novel Antibody Therapeutics in Autoimmune Diseases
November 4, 2025
·
3 min read
1 of 61,836
Next
